
|Articles|September 27, 2004
New help available for neonatal jaundice
Pediatricians have so much faith in a drug for treating neonatal hyperbilirubinemia that even though it hasn't been approved by the Food & Drug Administration yet, they are recommending its use in their just-released guidelines.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: Diverging Guidelines Undermine Confidence in Medicine, Health-Related News
2
Community Pharmacies Face Barriers Amid PBM Practices, Industry Shifts
3
PCV20 Shows Significant Cost-Savings, Health Benefits Compared With Previous Vaccines
4
Why PSOs Are Paramount in Ensuring Safe Medications, Clinical Services
5





































































































































